Caxton Associates (New York)’s Ovintiv OVV Stock Holding History

Caxton Associates (New York)’s Portfolio OVV Stock Details OVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-64,200	Closed	-$3.01M	–	617
2024 Q2	$3.01M	Buy	+64,200	New	+$3.23M	0.1%	101
2023 Q2	–	Sell	-14,345	Closed	-$518K	–	613
2023 Q1	$518K	Buy	+14,345	New	+$633K	0.08%	254
2021 Q4	–	Sell	-59,031	Closed	-$1.94M	–	647
2021 Q3	$1.94M	Buy	+59,031	New	+$1.63M	0.21%	49
2021 Q2	–	Sell	-38,400	Closed	-$915K	–	571
2021 Q1	$915K	Buy	+38,400	New	+$821K	0.08%	76
2017 Q1	–	Sell	-31,877	Closed	-$1.87M	–	432
2016 Q4	$1.87M	Buy	+31,877	New	+$1.82M	0.08%	160
2016 Q2	–	Sell	-34,000	Closed	-$1.03M	–	205
2016 Q1	$1.03M	Buy	+34,000	New	+$783K	0.07%	102

Other funds holding OVV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

SCM

Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caxton Associates (New York)'s OVV Position: Q3 2024 in Review

Caxton Associates (New York) sold out of Ovintiv (OVV) in Q3 2024, closing a stake of 64,200 shares — an estimated $3.01M sold.

Caxton Associates (New York) first reported a position in OVV in Q1 2016 and held it in 6 quarters. The position peaked at $3.01M in Q2 2024. 549 funds tracked by Wall St. Rank hold OVV as of Q3 2024.

Caxton Associates (New York) reported no remaining Ovintiv position as of Q3 2024 after selling out during the quarter.
Caxton Associates (New York) sold 64,200 Ovintiv shares in Q3 2024, an estimated $3.01M.
Caxton Associates (New York) first reported a position in Ovintiv in Q1 2016 and held it in 6 quarters.
Caxton Associates (New York)'s Ovintiv position peaked at $3.01M in Q2 2024.
549 funds tracked by Wall St. Rank held Ovintiv as of Q3 2024.

Based on Caxton Associates (New York)'s 13F filing for Q3 2024, filed 14 Nov 2024.